Cell Therapeutics for Corneal Diseases
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 20 February 2025 | Viewed by 28
Special Issue Editor
Interests: corneal wound healing; cornea trauma; keratoconus; bioengineering; bioprinting; diabetic keratopathy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce this Special Issue focused on “Cell Therapeutics for Corneal Diseases,” and we invite submissions of original research, comprehensive reviews, and clinical studies related to this evolving field. This Special Issue aims to showcase the latest advancements in cell-based therapies for treating various corneal conditions. We are particularly interested in research exploring the application of different types of stem cells, such as limbal stem cells and mesenchymal stem cells, in corneal repair and regeneration. Additionally, contributions that discuss innovative gene editing, molecular interventions, and engineering techniques are highly encouraged. This Special Issue will also feature reports on recent preclinical and clinical studies examining the effectiveness of cell-based applications in corneal conditions.
Authors are asked to follow Cells’s submission guidelines, which can be found on our website. For further information or inquiries, please contact the Special Issue Guest Editor or a journal representative. We look forward to receiving your valuable contributions that will advance the field of cell therapeutics in the treatment of corneal diseases.
Prof. Dr. Dimitrios Karamichos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell therapies
- corneal diseases
- drug development
- tissue engineering
- stem cells
- regeneration
- tissue repair
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
